Perfil
Caroline Roussel-Maupetit is the founder who has founded two companies.
In 1995, she founded Synt:em SA where she held the title of Chief Operations Officer until 2005.
In 2007, she founded Advicenne SA where she held the title of Operations Director & General Manager until 2020.
Ms. Roussel-Maupetit's former job was as a Marketing Manager at Proteine Performance.
She obtained an undergraduate degree from Université de Technologie de Compiègne.
Antiguos cargos conocidos de Caroline Roussel-Maupetit.
| Empresas | Cargo | Fin |
|---|---|---|
| ADVICENNE | Founder | 12/03/2020 |
Synt:em SA
 Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Founder | 01/01/2005 |
Proteine Performance
 Proteine Performance Medical SpecialtiesHealth Technology Part of Cystar, Proteine Performance is a French company that manufactures diagnostic products. The private company is based in Paris, France. Proteine Performance was acquired by Cystar on September 01, 1995 for $6.27 million. | Sales & Marketing | - |
Formación de Caroline Roussel-Maupetit.
| Université de Technologie de Compiègne | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ADVICENNE | Health Technology |
| Empresas privadas | 2 |
|---|---|
Proteine Performance
Proteine Performance Medical SpecialtiesHealth Technology Part of Cystar, Proteine Performance is a French company that manufactures diagnostic products. The private company is based in Paris, France. Proteine Performance was acquired by Cystar on September 01, 1995 for $6.27 million. | Health Technology |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Health Technology |
- Bolsa de valores
- Insiders
- Caroline Roussel-Maupetit
